chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Anaemia, Blood test, Catheter directed thrombolysis, Chest X-ray abnormal
Clinical narrative: BILATERAL DVT IN BOTH LEGS; SIGNIFICANT RIGHT HEART STRAIN; EXTENSIVE BILATERAL PULMONARY EMBOLISM; SHORTNESS OF BREATH; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included apixaban.  On 26-MAR-2021, the patient experienced shortness of breath (SOB). The patient went to emergency room (ER) on 04-APR-2021, it was found that she had extensive bilateral pulmonary embolism. On 05-APR-2021, the patient experienced bilateral deep vein thrombosis (DVT) in both legs and significant right heart strain. On 05-APR-2021, ekosonic endovascular system (EKOS) performed. She was currently on Eliquis for 1 year and she was following up with her physician very closely. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient's outcome for extensive bilateral pulmonary embolism, bilateral DVT in both legs, significant right heart strain, and shortness of breath were not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This concerns a female patient, unspecified age, unknown ethnicity, who was noted to have bilateral pulmonary embolism  and bilateral deep vein thrombosis on 20 days and 21 days, respectively, after receiving the Janssen Covid-19 vaccine. Patient's height and weight were not reported. Information regarding past medical history, smoking, alcohol use, and illicit drug use were not provided. Patient is currently taking apixaban for unknown indication and has been taking it for a year now.  Eleven (11) days after receiving the vaccine, patient experienced shortness of breath. He sought consult at the emergency room (ER) 20 days after receiving the vaccine and was noted to have extensive bilateral pulmonary embolism. The following day, 21 days after receiving the vaccine, the patient was noted to have deep vein thrombosis on both legs and significant right heart strain. Ekosonic endovascular system (EKOS) was performed. Based on the available information, the relationship with Janssen Covid-19 vaccine is considered indeterminate. More information (e.g. platelet count, D-dimer, fibrinogen, anti-platelet factor 4 antibodies, medical records) will be sought when contact information becomes available.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Dyspnoea, Echocardiogram abnormal, Electrocardiogram abnormal, Headache
Clinical narrative: BILATERAL DVT IN BOTH LEGS; SIGNIFICANT RIGHT HEART STRAIN; EXTENSIVE BILATERAL PULMONARY EMBOLISM; SHORTNESS OF BREATH; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included apixaban.  On 26-MAR-2021, the patient experienced shortness of breath (SOB). The patient went to emergency room (ER) on 04-APR-2021, it was found that she had extensive bilateral pulmonary embolism. On 05-APR-2021, the patient experienced bilateral deep vein thrombosis (DVT) in both legs and significant right heart strain. On 05-APR-2021, ekosonic endovascular system (EKOS) performed. She was currently on Eliquis for 1 year and she was following up with her physician very closely. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient's outcome for extensive bilateral pulmonary embolism, bilateral DVT in both legs, significant right heart strain, and shortness of breath were not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This concerns a female patient, unspecified age, unknown ethnicity, who was noted to have bilateral pulmonary embolism  and bilateral deep vein thrombosis on 20 days and 21 days, respectively, after receiving the Janssen Covid-19 vaccine. Patient's height and weight were not reported. Information regarding past medical history, smoking, alcohol use, and illicit drug use were not provided. Patient is currently taking apixaban for unknown indication and has been taking it for a year now.  Eleven (11) days after receiving the vaccine, patient experienced shortness of breath. He sought consult at the emergency room (ER) 20 days after receiving the vaccine and was noted to have extensive bilateral pulmonary embolism. The following day, 21 days after receiving the vaccine, the patient was noted to have deep vein thrombosis on both legs and significant right heart strain. Ekosonic endovascular system (EKOS) was performed. Based on the available information, the relationship with Janssen Covid-19 vaccine is considered indeterminate. More information (e.g. platelet count, D-dimer, fibrinogen, anti-platelet factor 4 antibodies, medical records) will be sought when contact information becomes available.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyponatraemia, Intensive care, Metabolic acidosis, Myocardial strain, Nausea
Clinical narrative: BILATERAL DVT IN BOTH LEGS; SIGNIFICANT RIGHT HEART STRAIN; EXTENSIVE BILATERAL PULMONARY EMBOLISM; SHORTNESS OF BREATH; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included apixaban.  On 26-MAR-2021, the patient experienced shortness of breath (SOB). The patient went to emergency room (ER) on 04-APR-2021, it was found that she had extensive bilateral pulmonary embolism. On 05-APR-2021, the patient experienced bilateral deep vein thrombosis (DVT) in both legs and significant right heart strain. On 05-APR-2021, ekosonic endovascular system (EKOS) performed. She was currently on Eliquis for 1 year and she was following up with her physician very closely. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient's outcome for extensive bilateral pulmonary embolism, bilateral DVT in both legs, significant right heart strain, and shortness of breath were not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This concerns a female patient, unspecified age, unknown ethnicity, who was noted to have bilateral pulmonary embolism  and bilateral deep vein thrombosis on 20 days and 21 days, respectively, after receiving the Janssen Covid-19 vaccine. Patient's height and weight were not reported. Information regarding past medical history, smoking, alcohol use, and illicit drug use were not provided. Patient is currently taking apixaban for unknown indication and has been taking it for a year now.  Eleven (11) days after receiving the vaccine, patient experienced shortness of breath. He sought consult at the emergency room (ER) 20 days after receiving the vaccine and was noted to have extensive bilateral pulmonary embolism. The following day, 21 days after receiving the vaccine, the patient was noted to have deep vein thrombosis on both legs and significant right heart strain. Ekosonic endovascular system (EKOS) was performed. Based on the available information, the relationship with Janssen Covid-19 vaccine is considered indeterminate. More information (e.g. platelet count, D-dimer, fibrinogen, anti-platelet factor 4 antibodies, medical records) will be sought when contact information becomes available.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism, Pulmonary function test abnormal, Ultrasound Doppler abnormal, Urine analysis, Vision blurred
Clinical narrative: BILATERAL DVT IN BOTH LEGS; SIGNIFICANT RIGHT HEART STRAIN; EXTENSIVE BILATERAL PULMONARY EMBOLISM; SHORTNESS OF BREATH; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included apixaban.  On 26-MAR-2021, the patient experienced shortness of breath (SOB). The patient went to emergency room (ER) on 04-APR-2021, it was found that she had extensive bilateral pulmonary embolism. On 05-APR-2021, the patient experienced bilateral deep vein thrombosis (DVT) in both legs and significant right heart strain. On 05-APR-2021, ekosonic endovascular system (EKOS) performed. She was currently on Eliquis for 1 year and she was following up with her physician very closely. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient's outcome for extensive bilateral pulmonary embolism, bilateral DVT in both legs, significant right heart strain, and shortness of breath were not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This concerns a female patient, unspecified age, unknown ethnicity, who was noted to have bilateral pulmonary embolism  and bilateral deep vein thrombosis on 20 days and 21 days, respectively, after receiving the Janssen Covid-19 vaccine. Patient's height and weight were not reported. Information regarding past medical history, smoking, alcohol use, and illicit drug use were not provided. Patient is currently taking apixaban for unknown indication and has been taking it for a year now.  Eleven (11) days after receiving the vaccine, patient experienced shortness of breath. He sought consult at the emergency room (ER) 20 days after receiving the vaccine and was noted to have extensive bilateral pulmonary embolism. The following day, 21 days after receiving the vaccine, the patient was noted to have deep vein thrombosis on both legs and significant right heart strain. Ekosonic endovascular system (EKOS) was performed. Based on the available information, the relationship with Janssen Covid-19 vaccine is considered indeterminate. More information (e.g. platelet count, D-dimer, fibrinogen, anti-platelet factor 4 antibodies, medical records) will be sought when contact information becomes available.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Dyspnoea, Pulmonary embolism, Right ventricular dysfunction
Clinical narrative: BILATERAL DVT IN BOTH LEGS; SIGNIFICANT RIGHT HEART STRAIN; EXTENSIVE BILATERAL PULMONARY EMBOLISM; SHORTNESS OF BREATH; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included apixaban.  On 26-MAR-2021, the patient experienced shortness of breath (SOB). The patient went to emergency room (ER) on 04-APR-2021, it was found that she had extensive bilateral pulmonary embolism. On 05-APR-2021, the patient experienced bilateral deep vein thrombosis (DVT) in both legs and significant right heart strain. On 05-APR-2021, ekosonic endovascular system (EKOS) performed. She was currently on Eliquis for 1 year and she was following up with her physician very closely. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient's outcome for extensive bilateral pulmonary embolism, bilateral DVT in both legs, significant right heart strain, and shortness of breath were not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This concerns a female patient, unspecified age, unknown ethnicity, who was noted to have bilateral pulmonary embolism  and bilateral deep vein thrombosis on 20 days and 21 days, respectively, after receiving the Janssen Covid-19 vaccine. Patient's height and weight were not reported. Information regarding past medical history, smoking, alcohol use, and illicit drug use were not provided. Patient is currently taking apixaban for unknown indication and has been taking it for a year now.  Eleven (11) days after receiving the vaccine, patient experienced shortness of breath. He sought consult at the emergency room (ER) 20 days after receiving the vaccine and was noted to have extensive bilateral pulmonary embolism. The following day, 21 days after receiving the vaccine, the patient was noted to have deep vein thrombosis on both legs and significant right heart strain. Ekosonic endovascular system (EKOS) was performed. Based on the available information, the relationship with Janssen Covid-19 vaccine is considered indeterminate. More information (e.g. platelet count, D-dimer, fibrinogen, anti-platelet factor 4 antibodies, medical records) will be sought when contact information becomes available.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID positive on 4/16/21, after completing her vaccination series on 1/23/21.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: Pt reports that approx. 4 days post-vaccination (4/10/21) at approx. 8pm she broke out with shingles on the right side of her torso (area where her bra-strap rest). Pt reports it is more of a discomfort than pain, minimal itching and feeling fatigue than usual. The shingles is healing and not spreading.   Pt reports she went to a walk-in clinic on 4/11/2021 and was advised she is experiencing a shingle outbreak. Pt was seen by her PCP on 4/16/2021, PCP confirmed pt is experiencing shingles or herpes outbreak and she was prescribed an antiviral (pt report she will finish the course of tx by 4/22/21). Pt also report that her PCP advised her it was ok to get the 2nd dose of Moderna. Pt also reported that she had her 1st shingles outbreak in 9/2020 in the same torso area, during that outbreak she experienced tingling down half her body and had shooting pain for 3 days. Advised pt this was not a contraindication from getting her second dose scheduled for 5/1/2021. Advised pt that according to health officials there's no scientific evidence that the covid vaccine is linked to shingles; and that shingles appears to be triggered partially by a drecease in immunity; and outbreaks are often linked to stress and especially with previous history of prior outbreaks it can reoccur in certain pt. Advised that more data is being collected on the vaccine and any ADEs that occurred is being documented at this time. Also recommend pt to speak with her PCP regarding getting vaccinated for shingles after she complete her covid vaccine series; advised other vaccines must be given 14 post covid vaccine. Also recommend that if pt have and common symptoms of ADEs from her 2nd Moderna dose such as headache, body ache, or fever can take Tylenol PRN and stay hydrated.  4/27-, she states that she has her energy back and only a small remnant of the rash is left. Overall she feels fine and said that she appreciates the call and the people in our department has been so sweet. I will close case.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Discomfort, Fatigue, Herpes zoster, Pruritus
Clinical narrative: Pt reports that approx. 4 days post-vaccination (4/10/21) at approx. 8pm she broke out with shingles on the right side of her torso (area where her bra-strap rest). Pt reports it is more of a discomfort than pain, minimal itching and feeling fatigue than usual. The shingles is healing and not spreading.   Pt reports she went to a walk-in clinic on 4/11/2021 and was advised she is experiencing a shingle outbreak. Pt was seen by her PCP on 4/16/2021, PCP confirmed pt is experiencing shingles or herpes outbreak and she was prescribed an antiviral (pt report she will finish the course of tx by 4/22/21). Pt also report that her PCP advised her it was ok to get the 2nd dose of Moderna. Pt also reported that she had her 1st shingles outbreak in 9/2020 in the same torso area, during that outbreak she experienced tingling down half her body and had shooting pain for 3 days. Advised pt this was not a contraindication from getting her second dose scheduled for 5/1/2021. Advised pt that according to health officials there's no scientific evidence that the covid vaccine is linked to shingles; and that shingles appears to be triggered partially by a drecease in immunity; and outbreaks are often linked to stress and especially with previous history of prior outbreaks it can reoccur in certain pt. Advised that more data is being collected on the vaccine and any ADEs that occurred is being documented at this time. Also recommend pt to speak with her PCP regarding getting vaccinated for shingles after she complete her covid vaccine series; advised other vaccines must be given 14 post covid vaccine. Also recommend that if pt have and common symptoms of ADEs from her 2nd Moderna dose such as headache, body ache, or fever can take Tylenol PRN and stay hydrated.  4/27-, she states that she has her energy back and only a small remnant of the rash is left. Overall she feels fine and said that she appreciates the call and the people in our department has been so sweet. I will close case.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Eye disorder, Eye swelling, Swelling face
Clinical narrative: CAPILLARY LEAKAGE; SWELLING OF FACE; SWELLING OF EYES; This spontaneous report received from a consumer concerned a 92 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included cardiovascular disease, and polyethylene glycol, polysorbate allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808978, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 09:46 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid, colecalciferol, diltiazem, losartan, metformin, and risedronate sodium. On 09-APR-2021 18:01, the subject experienced capillary leakage. On 09-APR-2021 18:01, the subject experienced swelling of face. On 09-APR-2021 18:01, the subject experienced swelling of eyes. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the swelling of face, capillary leakage and swelling of eyes was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non serious
Age: 54.0
Sex: F
Vaccine: VARZOS, PPV, VARZOS
Symptoms: Abdominal pain upper, Malaise, Pyrexia
Clinical narrative: could hardly move her arm where she received the injection; both of her arms hurt; temperature of 102.9; severe stomach pain; received Shingirx along with a pneumonia vaccine in her left arm; This case was reported by a consumer and described the occurrence of injected limb mobility decreased in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE) for prophylaxis.   The patient's past medical history included chickenpox (bad case as a child).   On 25th January 2021, the patient received the 2nd dose of Shingrix (intramuscular) and PNEUMONIA VACCINE. On 25th January 2021, unknown after receiving Shingrix, the patient experienced vaccine administered at inappropriate site. On an unknown date, the patient experienced injected limb mobility decreased, pain in arm, fever and stomach pain. On an unknown date, the outcome of the injected limb mobility decreased, pain in arm, fever and stomach pain were recovered/resolved and the outcome of the vaccine administered at inappropriate site was unknown.   It was unknown if the reporter considered the injected limb mobility decreased, pain in arm, fever and stomach pain to be related to Shingrix.  Additional details were provided as follows: The patient reported case for herself. The patient had no history of shingles. The patient received Shingirx along with a pneumonia vaccine in her left arm, which led to vaccine administered at inappropriate site. The patient reported in less than 3 months after the vaccination, both of her arms hurt and she could hardly move her arm where she received the injection. She also had a severe stomach pain and a temperature of 102.9 degrees F. It was unknown if the reporter considered the injected limb mobility decreased, pain in arm, fever and stomach pain to be related to PNEUMONIA VACCINE. The reporter consented to follow up. For tolerance after 2nd dose, refer case US2021AMR091095.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR091095:same reporter
Age: 54.0
Sex: F
Vaccine: VARZOS, PPV, VARZOS
Symptoms: Abdominal pain upper, Injected limb mobility decreased, Pain in extremity, Product administered at inappropriate site, Pyrexia
Clinical narrative: could hardly move her arm where she received the injection; both of her arms hurt; temperature of 102.9; severe stomach pain; received Shingirx along with a pneumonia vaccine in her left arm; This case was reported by a consumer and described the occurrence of injected limb mobility decreased in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE) for prophylaxis.   The patient's past medical history included chickenpox (bad case as a child).   On 25th January 2021, the patient received the 2nd dose of Shingrix (intramuscular) and PNEUMONIA VACCINE. On 25th January 2021, unknown after receiving Shingrix, the patient experienced vaccine administered at inappropriate site. On an unknown date, the patient experienced injected limb mobility decreased, pain in arm, fever and stomach pain. On an unknown date, the outcome of the injected limb mobility decreased, pain in arm, fever and stomach pain were recovered/resolved and the outcome of the vaccine administered at inappropriate site was unknown.   It was unknown if the reporter considered the injected limb mobility decreased, pain in arm, fever and stomach pain to be related to Shingrix.  Additional details were provided as follows: The patient reported case for herself. The patient had no history of shingles. The patient received Shingirx along with a pneumonia vaccine in her left arm, which led to vaccine administered at inappropriate site. The patient reported in less than 3 months after the vaccination, both of her arms hurt and she could hardly move her arm where she received the injection. She also had a severe stomach pain and a temperature of 102.9 degrees F. It was unknown if the reporter considered the injected limb mobility decreased, pain in arm, fever and stomach pain to be related to PNEUMONIA VACCINE. The reporter consented to follow up. For tolerance after 2nd dose, refer case US2021AMR091095.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR091095:same reporter
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angina pectoris, Arteriogram coronary abnormal, Atrial fibrillation, Cardiac arrest, Cardioversion
Clinical narrative: office was notified patient was admitted to hospital on 4/15/21 , Lung Specialist stated he was sedated/intubated on vent due to clinical condition, impression cardiogenic shock, stemi s/p emergent LHC w acute thrombotic occlusions, v-fib cardiac arrest requiring defibrillation x 2
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Catheterisation cardiac abnormal, Condition aggravated, Coronary angioplasty, Coronary artery occlusion, Coronary artery thrombosis
Clinical narrative: office was notified patient was admitted to hospital on 4/15/21 , Lung Specialist stated he was sedated/intubated on vent due to clinical condition, impression cardiogenic shock, stemi s/p emergent LHC w acute thrombotic occlusions, v-fib cardiac arrest requiring defibrillation x 2
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram ST segment elevation, Endotracheal intubation, Intensive care, Platelet count decreased, Resuscitation
Clinical narrative: office was notified patient was admitted to hospital on 4/15/21 , Lung Specialist stated he was sedated/intubated on vent due to clinical condition, impression cardiogenic shock, stemi s/p emergent LHC w acute thrombotic occlusions, v-fib cardiac arrest requiring defibrillation x 2
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thrombectomy, Ventricular assist device insertion, Ventricular fibrillation
Clinical narrative: office was notified patient was admitted to hospital on 4/15/21 , Lung Specialist stated he was sedated/intubated on vent due to clinical condition, impression cardiogenic shock, stemi s/p emergent LHC w acute thrombotic occlusions, v-fib cardiac arrest requiring defibrillation x 2
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute myocardial infarction, Cardiac arrest, Cardiogenic shock, Cardioversion, Catheterisation cardiac abnormal
Clinical narrative: office was notified patient was admitted to hospital on 4/15/21 , Lung Specialist stated he was sedated/intubated on vent due to clinical condition, impression cardiogenic shock, stemi s/p emergent LHC w acute thrombotic occlusions, v-fib cardiac arrest requiring defibrillation x 2
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Mechanical ventilation, Thrombosis, Ventricular fibrillation
Clinical narrative: office was notified patient was admitted to hospital on 4/15/21 , Lung Specialist stated he was sedated/intubated on vent due to clinical condition, impression cardiogenic shock, stemi s/p emergent LHC w acute thrombotic occlusions, v-fib cardiac arrest requiring defibrillation x 2
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute myocardial infarction, Angina pectoris, Angiogram, Arteriogram coronary abnormal, Atrial fibrillation
Clinical narrative: office was notified patient was admitted to hospital on 4/15/21 , Lung Specialist stated he was sedated/intubated on vent due to clinical condition, impression cardiogenic shock, stemi s/p emergent LHC w acute thrombotic occlusions, v-fib cardiac arrest requiring defibrillation x 2
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac arrest, Cardiogenic shock, Cardioversion, Catheterisation cardiac abnormal, Condition aggravated
Clinical narrative: office was notified patient was admitted to hospital on 4/15/21 , Lung Specialist stated he was sedated/intubated on vent due to clinical condition, impression cardiogenic shock, stemi s/p emergent LHC w acute thrombotic occlusions, v-fib cardiac arrest requiring defibrillation x 2
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Coronary angioplasty, Coronary artery occlusion, Coronary artery thrombosis, Electrocardiogram, Electrocardiogram ST segment elevation
Clinical narrative: office was notified patient was admitted to hospital on 4/15/21 , Lung Specialist stated he was sedated/intubated on vent due to clinical condition, impression cardiogenic shock, stemi s/p emergent LHC w acute thrombotic occlusions, v-fib cardiac arrest requiring defibrillation x 2
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Intensive care, Mechanical ventilation, Platelet count, Platelet count decreased
Clinical narrative: office was notified patient was admitted to hospital on 4/15/21 , Lung Specialist stated he was sedated/intubated on vent due to clinical condition, impression cardiogenic shock, stemi s/p emergent LHC w acute thrombotic occlusions, v-fib cardiac arrest requiring defibrillation x 2
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Resuscitation, Thrombectomy, Thrombosis, Ventricular assist device insertion, Ventricular fibrillation
Clinical narrative: office was notified patient was admitted to hospital on 4/15/21 , Lung Specialist stated he was sedated/intubated on vent due to clinical condition, impression cardiogenic shock, stemi s/p emergent LHC w acute thrombotic occlusions, v-fib cardiac arrest requiring defibrillation x 2
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Adverse event, Amnesia, Blood test, Computerised tomogram, Confusional state
Clinical narrative: SLEPT MORE THAN NORMAL; TRANSIENT GLOBAL AMNESIA; FLUID IN BOTH LUNGS; DISORIENTED FOR 5 DAYS POST HOSPITALZATION; VERY TIRED FOR 5 DAYS POST HOSPITALZATION; This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's past medical history included arthritis, and reaction to penicillin, and concurrent conditions included non smoker, alcohol use, and tree pollen allergies, and other pre-existing medical conditions included the patient had no known drug allergies and no any drug abuse / illicit drug use.  The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070 expiry: UNKNOWN) dose was not reported, 1 total administered on 03-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, patient had sudden onset of long and short term memory loss her neighbor further took her emergency room and diagnosed with transient global amnesia. She had many immunizations without any side effects. The patient reported she used to sleep more than normal for 2 days, during hospitalization patient was identified with fluid in both of her lungs, and got discharged on 08-APR-2021. She felt very tried and disoriented for 5 days post hospitalization. She had no cough and no runny nose. Symptoms lasted for approximately for 8 hours on 07-APR-2021 and she started regaining her memory at around 7-8 hours and was able to recall the activities. Laboratory data included: Blood sugar abnormal (NR: not provided) Unknown, complete blood count (NR: not provided) Unknown, Computerized tomogram scan (NR: not provided) Head neck normal, Chest X-ray (NR: not provided) Unknown, Drug screen (NR: not provided) Unknown, Electrocardiogram (NR: not provided) Unknown, Electroencephalogram (NR: not provided) Unknown, Echocardiogram (NR: not provided) Unknown, Low density lipoprotein cholesterol high (NR: not provided) Unknown, MRI (NR: not provided) Brain no contrast, TSH (NR: not provided) Unknown, and Urine analysis (NR: not provided) Unknown.  The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from transient global amnesia, fluid in both lungs and  slept more than normal and had not recovered from disoriented and very tired. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0- Covid-19 vaccine ad26.cov2.s-Transient global amnesia, Fluid in both lungs, Slept more than normal. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Disorientation, Electroencephalogram, Emotional distress, Fatigue, Magnetic resonance imaging
Clinical narrative: SLEPT MORE THAN NORMAL; TRANSIENT GLOBAL AMNESIA; FLUID IN BOTH LUNGS; DISORIENTED FOR 5 DAYS POST HOSPITALZATION; VERY TIRED FOR 5 DAYS POST HOSPITALZATION; This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's past medical history included arthritis, and reaction to penicillin, and concurrent conditions included non smoker, alcohol use, and tree pollen allergies, and other pre-existing medical conditions included the patient had no known drug allergies and no any drug abuse / illicit drug use.  The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070 expiry: UNKNOWN) dose was not reported, 1 total administered on 03-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, patient had sudden onset of long and short term memory loss her neighbor further took her emergency room and diagnosed with transient global amnesia. She had many immunizations without any side effects. The patient reported she used to sleep more than normal for 2 days, during hospitalization patient was identified with fluid in both of her lungs, and got discharged on 08-APR-2021. She felt very tried and disoriented for 5 days post hospitalization. She had no cough and no runny nose. Symptoms lasted for approximately for 8 hours on 07-APR-2021 and she started regaining her memory at around 7-8 hours and was able to recall the activities. Laboratory data included: Blood sugar abnormal (NR: not provided) Unknown, complete blood count (NR: not provided) Unknown, Computerized tomogram scan (NR: not provided) Head neck normal, Chest X-ray (NR: not provided) Unknown, Drug screen (NR: not provided) Unknown, Electrocardiogram (NR: not provided) Unknown, Electroencephalogram (NR: not provided) Unknown, Echocardiogram (NR: not provided) Unknown, Low density lipoprotein cholesterol high (NR: not provided) Unknown, MRI (NR: not provided) Brain no contrast, TSH (NR: not provided) Unknown, and Urine analysis (NR: not provided) Unknown.  The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from transient global amnesia, fluid in both lungs and  slept more than normal and had not recovered from disoriented and very tired. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0- Covid-19 vaccine ad26.cov2.s-Transient global amnesia, Fluid in both lungs, Slept more than normal. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Transient global amnesia, Urine analysis, X-ray
Clinical narrative: SLEPT MORE THAN NORMAL; TRANSIENT GLOBAL AMNESIA; FLUID IN BOTH LUNGS; DISORIENTED FOR 5 DAYS POST HOSPITALZATION; VERY TIRED FOR 5 DAYS POST HOSPITALZATION; This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's past medical history included arthritis, and reaction to penicillin, and concurrent conditions included non smoker, alcohol use, and tree pollen allergies, and other pre-existing medical conditions included the patient had no known drug allergies and no any drug abuse / illicit drug use.  The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070 expiry: UNKNOWN) dose was not reported, 1 total administered on 03-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, patient had sudden onset of long and short term memory loss her neighbor further took her emergency room and diagnosed with transient global amnesia. She had many immunizations without any side effects. The patient reported she used to sleep more than normal for 2 days, during hospitalization patient was identified with fluid in both of her lungs, and got discharged on 08-APR-2021. She felt very tried and disoriented for 5 days post hospitalization. She had no cough and no runny nose. Symptoms lasted for approximately for 8 hours on 07-APR-2021 and she started regaining her memory at around 7-8 hours and was able to recall the activities. Laboratory data included: Blood sugar abnormal (NR: not provided) Unknown, complete blood count (NR: not provided) Unknown, Computerized tomogram scan (NR: not provided) Head neck normal, Chest X-ray (NR: not provided) Unknown, Drug screen (NR: not provided) Unknown, Electrocardiogram (NR: not provided) Unknown, Electroencephalogram (NR: not provided) Unknown, Echocardiogram (NR: not provided) Unknown, Low density lipoprotein cholesterol high (NR: not provided) Unknown, MRI (NR: not provided) Brain no contrast, TSH (NR: not provided) Unknown, and Urine analysis (NR: not provided) Unknown.  The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from transient global amnesia, fluid in both lungs and  slept more than normal and had not recovered from disoriented and very tired. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0- Covid-19 vaccine ad26.cov2.s-Transient global amnesia, Fluid in both lungs, Slept more than normal. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose abnormal, Blood thyroid stimulating hormone, Chest X-ray, Computerised tomogram, Disorientation
Clinical narrative: SLEPT MORE THAN NORMAL; TRANSIENT GLOBAL AMNESIA; FLUID IN BOTH LUNGS; DISORIENTED FOR 5 DAYS POST HOSPITALZATION; VERY TIRED FOR 5 DAYS POST HOSPITALZATION; This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's past medical history included arthritis, and reaction to penicillin, and concurrent conditions included non smoker, alcohol use, and tree pollen allergies, and other pre-existing medical conditions included the patient had no known drug allergies and no any drug abuse / illicit drug use.  The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070 expiry: UNKNOWN) dose was not reported, 1 total administered on 03-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, patient had sudden onset of long and short term memory loss her neighbor further took her emergency room and diagnosed with transient global amnesia. She had many immunizations without any side effects. The patient reported she used to sleep more than normal for 2 days, during hospitalization patient was identified with fluid in both of her lungs, and got discharged on 08-APR-2021. She felt very tried and disoriented for 5 days post hospitalization. She had no cough and no runny nose. Symptoms lasted for approximately for 8 hours on 07-APR-2021 and she started regaining her memory at around 7-8 hours and was able to recall the activities. Laboratory data included: Blood sugar abnormal (NR: not provided) Unknown, complete blood count (NR: not provided) Unknown, Computerized tomogram scan (NR: not provided) Head neck normal, Chest X-ray (NR: not provided) Unknown, Drug screen (NR: not provided) Unknown, Electrocardiogram (NR: not provided) Unknown, Electroencephalogram (NR: not provided) Unknown, Echocardiogram (NR: not provided) Unknown, Low density lipoprotein cholesterol high (NR: not provided) Unknown, MRI (NR: not provided) Brain no contrast, TSH (NR: not provided) Unknown, and Urine analysis (NR: not provided) Unknown.  The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from transient global amnesia, fluid in both lungs and  slept more than normal and had not recovered from disoriented and very tired. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0- Covid-19 vaccine ad26.cov2.s-Transient global amnesia, Fluid in both lungs, Slept more than normal. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Drug screen, Echocardiogram, Electrocardiogram, Electroencephalogram, Fatigue
Clinical narrative: SLEPT MORE THAN NORMAL; TRANSIENT GLOBAL AMNESIA; FLUID IN BOTH LUNGS; DISORIENTED FOR 5 DAYS POST HOSPITALZATION; VERY TIRED FOR 5 DAYS POST HOSPITALZATION; This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's past medical history included arthritis, and reaction to penicillin, and concurrent conditions included non smoker, alcohol use, and tree pollen allergies, and other pre-existing medical conditions included the patient had no known drug allergies and no any drug abuse / illicit drug use.  The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070 expiry: UNKNOWN) dose was not reported, 1 total administered on 03-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, patient had sudden onset of long and short term memory loss her neighbor further took her emergency room and diagnosed with transient global amnesia. She had many immunizations without any side effects. The patient reported she used to sleep more than normal for 2 days, during hospitalization patient was identified with fluid in both of her lungs, and got discharged on 08-APR-2021. She felt very tried and disoriented for 5 days post hospitalization. She had no cough and no runny nose. Symptoms lasted for approximately for 8 hours on 07-APR-2021 and she started regaining her memory at around 7-8 hours and was able to recall the activities. Laboratory data included: Blood sugar abnormal (NR: not provided) Unknown, complete blood count (NR: not provided) Unknown, Computerized tomogram scan (NR: not provided) Head neck normal, Chest X-ray (NR: not provided) Unknown, Drug screen (NR: not provided) Unknown, Electrocardiogram (NR: not provided) Unknown, Electroencephalogram (NR: not provided) Unknown, Echocardiogram (NR: not provided) Unknown, Low density lipoprotein cholesterol high (NR: not provided) Unknown, MRI (NR: not provided) Brain no contrast, TSH (NR: not provided) Unknown, and Urine analysis (NR: not provided) Unknown.  The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from transient global amnesia, fluid in both lungs and  slept more than normal and had not recovered from disoriented and very tired. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0- Covid-19 vaccine ad26.cov2.s-Transient global amnesia, Fluid in both lungs, Slept more than normal. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Hypersomnia, Low density lipoprotein increased, Magnetic resonance imaging, Pulmonary oedema
Clinical narrative: SLEPT MORE THAN NORMAL; TRANSIENT GLOBAL AMNESIA; FLUID IN BOTH LUNGS; DISORIENTED FOR 5 DAYS POST HOSPITALZATION; VERY TIRED FOR 5 DAYS POST HOSPITALZATION; This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's past medical history included arthritis, and reaction to penicillin, and concurrent conditions included non smoker, alcohol use, and tree pollen allergies, and other pre-existing medical conditions included the patient had no known drug allergies and no any drug abuse / illicit drug use.  The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070 expiry: UNKNOWN) dose was not reported, 1 total administered on 03-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, patient had sudden onset of long and short term memory loss her neighbor further took her emergency room and diagnosed with transient global amnesia. She had many immunizations without any side effects. The patient reported she used to sleep more than normal for 2 days, during hospitalization patient was identified with fluid in both of her lungs, and got discharged on 08-APR-2021. She felt very tried and disoriented for 5 days post hospitalization. She had no cough and no runny nose. Symptoms lasted for approximately for 8 hours on 07-APR-2021 and she started regaining her memory at around 7-8 hours and was able to recall the activities. Laboratory data included: Blood sugar abnormal (NR: not provided) Unknown, complete blood count (NR: not provided) Unknown, Computerized tomogram scan (NR: not provided) Head neck normal, Chest X-ray (NR: not provided) Unknown, Drug screen (NR: not provided) Unknown, Electrocardiogram (NR: not provided) Unknown, Electroencephalogram (NR: not provided) Unknown, Echocardiogram (NR: not provided) Unknown, Low density lipoprotein cholesterol high (NR: not provided) Unknown, MRI (NR: not provided) Brain no contrast, TSH (NR: not provided) Unknown, and Urine analysis (NR: not provided) Unknown.  The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from transient global amnesia, fluid in both lungs and  slept more than normal and had not recovered from disoriented and very tired. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0- Covid-19 vaccine ad26.cov2.s-Transient global amnesia, Fluid in both lungs, Slept more than normal. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).